By: Elias Visontay
Banned from spruiking prescription medications in Australia, the global companies behind weight loss drugs like Ozempic and Mounjaro try to lure consumers with emotional awareness campaigns.


Elias Visontay is a Reporter at The Sydney Morning Herald and The Age. He focuses on areas such as transportation and mobility, real estate, and retail, examining topics like housing markets, transportation policy, and store management. Elias has been featured in prominent publications including MSN, The Irish Times, and The Guardian.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)


Not enough data
Elias Visontay's coverage encompasses a broad range of topics, including government and politics, business and industry. He frequently reports on government announcements, legal policy regulation, and cites data in his articles.
When reaching out to Elias with pitches or information, consider providing insights related to government policies or regulations within Australia. Topics such as car sales trends, transportation issues (like flight delays), urban planning developments and infrastructure projects could be of particular interest based on his coverage attributes.
Given the diverse themes covered by Elias's articles, sources with expertise in public policy development or regulatory affairs may find success when offering commentary or analysis tailored specifically to the Australian context.
This information evolves through artificial intelligence and human feedback. Improve this profile .